The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
Abstract Background The benefit-risk profile of direct oral anticoagulants (DOAC) therapy in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) has not been well established yet. This study aimed to evaluate the efficacy and safety of DOAC compared with vitamin K antagonist...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
BMC
2024-01-01
|
| Schriftenreihe: | Thrombosis Journal |
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1186/s12959-023-00562-8 |